Top section
Top section
Deal could include $950m of bonds
Upper mid-market firms eschew ‘exciting’ stories as cracks emerge in European private credit
Pharmaceuticals and energy transition also ripe sectors for M&A
More articles
More articles
More articles
-
-
Biofarma Group launches €345m high yield bond -
The primary leveraged finance market is beginning to churn out deals again. The first European high yield deal in 10 weeks is expected to be priced this week and a handful of leveraged loans have begun the pricing process.
-
Technical difficulty and disagreements about responsibility impede progress
-
Better pricing conditions are enabling managers to refresh old deals
-
Sub-sections
shared comment list
